Pharma Spares Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.50 Cr
as on 07-07-2024
- Revenue 29.25%
(FY 2021)
- Profit 193.23%
(FY 2021)
- Ebitda 192.81%
(FY 2021)
- Net Worth 16.63%
(FY 2021)
- Total Assets 17.85%
(FY 2021)
About Pharma Spares
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanjay Gandhi, Anisha Gandhi, and Sunita Gandhi serve as directors at the Company.
- CIN/LLPIN
U29253MH2012PTC229718
- Company No.
229718
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pharma Spares Private Limited offer?
Pharma Spares Private Limited offers a wide range of products and services, including Separator Equipments, Lead Free Sieves, Separators, Strainers & Purifiers.
Who are the key members and board of directors at Pharma Spares?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gandhi  | Director | 16-Apr-2012 | Current |
| Anisha Gandhi | Director | 16-Apr-2012 | Current |
| Sunita Gandhi | Director | 16-Apr-2012 | Current |
Financial Performance of Pharma Spares.
Pharma Spares Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 29.25% increase. The company also saw a substantial improvement in profitability, with a 193.23% increase in profit. The company's net worth Soared by an impressive increase of 16.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Spares?
In 2021, Pharma Spares had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Nov 2019 | ₹1.50 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 31 Mar 2017 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Pharma Spares?
Pharma Spares has a workforce of 41 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Spares, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Spares's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
